CPR Investments’s Oracle ORCL Stock Holding History

CPR Investments’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,168	Closed	-$593K	–	72
2022 Q1	$593K	Buy	7,168 +153	+2%	+$12.4K	0.49%	27
2021 Q4	$612K	Buy	+7,015	New	+$659K	0.44%	25

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CPR Investments's ORCL Position: Q2 2022 in Review

CPR Investments sold out of Oracle (ORCL) in Q2 2022, closing a stake of 7,168 shares — an estimated $593K sold.

CPR Investments first reported a position in ORCL in Q4 2021 and held it in 2 quarters. The position peaked at $612K in Q4 2021. 2,191 funds tracked by Wall St. Rank hold ORCL as of Q2 2022.

CPR Investments reported no remaining Oracle position as of Q2 2022 after selling out during the quarter.
CPR Investments sold 7,168 Oracle shares in Q2 2022, an estimated $593K.
CPR Investments first reported a position in Oracle in Q4 2021 and held it in 2 quarters.
CPR Investments's Oracle position peaked at $612K in Q4 2021.
2,191 funds tracked by Wall St. Rank held Oracle as of Q2 2022.

Based on CPR Investments's 13F filing for Q2 2022, filed 11 Aug 2022.